Exposure to Recycled Uranium Contaminants in Gaseous Diffusion Plants.

Radiat Prot Dosimetry

Division of Surveillance, Hazard Evaluations and Field Studies (DSHEFS), National Institute for Occupational Safety and Health (NIOSH), Cincinnati, OH45226, USA.

Published: August 2017

As part of an ongoing study of health effects in a pooled cohort of gaseous diffusion plant workers, organ dose from internal exposure to uranium was evaluated. Due to the introduction of recycled uranium into the plants, there was also potential for exposure to radiologically significant levels of 99Tc, 237Np and 238,239Pu. In the evaluation of dose response, these radionuclide exposures could confound the effect of internal uranium. Using urine bioassay data for study subjects reported in facility records, intakes and absorbed dose to bone surface, red bone marrow and kidneys were estimated as these organs were associated with a priori outcomes of interest. Additionally, 99Tc intakes and doses were calculated using a new systemic model for technetium and compared to intakes and doses calculated using the current model recommended by the International Commission on Radiological Protection. Organ absorbed doses for the transuranics were significant compared to uranium doses; however, 99Tc doses calculated using the new systemic model were significant as well. Use of the new model resulted in an increase in 99Tc-related absorbed organ dose of a factor of 8 (red bone marrow) to 30 (bone surface).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892198PMC
http://dx.doi.org/10.1093/rpd/ncw379DOI Listing

Publication Analysis

Top Keywords

doses calculated
12
recycled uranium
8
gaseous diffusion
8
organ dose
8
bone surface
8
red bone
8
bone marrow
8
intakes doses
8
calculated systemic
8
systemic model
8

Similar Publications

Dose Recommendations for Prostrate-specific Membrane Antigen Positron Emission Tomography (PSMA PET) Guided Boost Irradiation to Lymphatic Tissue in Prostate Adenocarcinoma.

Clin Oncol (R Coll Radiol)

December 2024

Alberta Health Services, South Zone, Lethbridge, AB, Canada; University of Calgary, Department of Oncology, Calgary, AB, Canada; University of Calgary, Department of Physics and Astronomy, Calgary, AB, Canada.

Aims: Prostrate-specific membrane antigen positron emission tomography (PSMA-PET) imaging has led to an increase in identifiable small volume metastatic disease in prostate adenocarcinoma. There is clinical equipoise in how to treat these using radiotherapy regimens. The aim of this study is to determine an adequate dosing regimen for small volume lymphatic metastases in prostate adenocarcinoma.

View Article and Find Full Text PDF

Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck.

Radiother Oncol

December 2024

Medical Physics Unit, IRCCS, Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Italy. Electronic address:

Purpose: This study aims to investigate and compare High Dose Rate Brachytherapy (HDR-BT) with Helical Tomotherapy (HT) treatment plans. The focus is on small target volumes near radiation-sensitive organs in the ocular region, to evaluate the advantages of these techniques in treating skin cancer.

Methods: This retrospective observational analysis included patients who underwent skin cancer HDR-BT Freiburg flap treatment between 2019 and 2023.

View Article and Find Full Text PDF

Aim: To study the dosimetric behavior of dose computational algorithms in inhomogeneous medium using CMS XiO and MONACO treatment planning system (TPS) for 4 megavoltage (MV), 6 MV and 15 MV photon beam energies.

Material And Methods: Styrofoam blocks of thickness 1.90 cm, 3.

View Article and Find Full Text PDF

Background: Excessive submental fat under the chin is a known aesthetic concern because of its negative impact on facial appearance and psychological well-being. AYP-101 is a newly developed injectable agent containing 93% soybean phosphatidylcholine (SPC) designed to reduce submental fat. We conducted a phase 1 study to evaluate the safety, pharmacokinetic (PK), and lipid profile effects of AYP-101.

View Article and Find Full Text PDF

[Investigation of general toxic effects of Relatox in comparison with Dysport].

Zh Nevrol Psikhiatr Im S S Korsakova

December 2024

OOO NBC «Pharmbiomed», Moscow, Russia.

Objective: To evaluate the toxic effects of the agent Relatox on mature outbred rats and mice in an acute experiment in comparison with the registered analogue Dysport.

Material And Methods: Based on the aim of experiment, the acute toxic effects of Relatox and Dysport were assessed on two animal species: rats and mice at intraperitoneal and intramuscular administration at dose levels that made it possible to calculate the toxicological parameter values (initially 10-150 U/kg with subsequent usage of additional doses 20 U/kg to 300 U/kg depending on the agent and route of administration). The LD values and other acute toxic parameters were calculated using probit analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!